Abstract:

In this paper it is hoped to examine some of the problems which confront companies which have new compounds showing promise and which are likely to be available as ethical prescription products after the successful conclusion of clinical trials. These problems will not be unknown to those engaged in International Marketing Research. However, the purpose of this seminar is to identify and discuss specific information needs and how these may be satisfied. Some of what will be said may be provocative and hopefully may stimulate discussion.